Figure 7.

(A) Illustration of a) preparation and b) synergistic cancer therapy of CFAP. Reproduced with permission ¹⁵⁹. Copyright 2020, American Chemical Society. (B) Schematic illustration for the a) preparation of P/G@EF-TKNPs and b) mechanism of in vivo CombinationTherapy of CDT and ICB ¹⁶¹. Copyright 2022, American Chemical Society. (C) Schematic illustration of the preparation of FePt/BP-PEI-FA NCs and dual-modal imaging (MR and thermal imaging)-guided synergistic PTT/PDT/CDT cancer therapies as well as photothermally-enhanced immunotherapy. Reproduced with permission ¹⁶³. Copyright 2020, The Royal Society of Chemistry. (D) Illustration of MnOx-OVA/tumor cell fragment (TF) nanovaccines for MR/PA dual-mode imaging-induced cancer immunotherapy. Reproduced with permission ¹⁶⁸. Copyright 2020, Wiley-VCH.